Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,508 | -13,592 | -10,346 | -6,896 | -3,622 |
| Depreciation Amortization | 126 | 185 | 69 | 50 | 32 |
| Accounts receivable | -38 | 210 | 236 | 324 | 3 |
| Other Working Capital | -829 | -461 | -474 | -541 | -1,248 |
| Other Operating Activity | 361 | 1,406 | 1,067 | 661 | 522 |
| Operating Cash Flow | $-3,888 | $-12,252 | $-9,448 | $-6,402 | $-4,313 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,214 | -20,517 | -11,835 | 991 | -2 |
| PPE Investments | N/A | -20 | -13 | -11 | -7 |
| Investing Cash Flow | $2,214 | $-20,537 | $-11,848 | $980 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -6 | -5 | -3 | -2 |
| Common Stock Issued | N/A | 30,093 | 30,111 | 244 | 244 |
| Financing Cash Flow | $-1 | $30,087 | $30,106 | $241 | $242 |
| Beginning Cash Position | 4,707 | 7,409 | 7,409 | 7,409 | 7,409 |
| End Cash Position | 3,032 | 4,707 | 16,219 | 2,228 | 3,329 |
| Net Cash Flow | $-1,675 | $-2,702 | $8,810 | $-5,181 | $-4,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,888 | -12,252 | -9,448 | -6,402 | -4,313 |
| Capital Expenditure | 0 | -22 | -15 | -13 | -9 |
| Free Cash Flow | -3,888 | -12,274 | -9,463 | -6,415 | -4,322 |